Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test

Completed

Conditions studied: Factor V Leiden, Factor II, Thrombosis

In brief

To establish the overall agreement of the MassPLEX Factor II and Factor V Leiden Genotyping Test with bi-directional DNA sequencing for Factor II and Factor V Leiden.

Key facts

Study ID

NCT01835483

Run by

Sequenom, Inc.

People needed

867

Starts

2013-05-01

Expected to finish

2013-07-01

Last updated by the study team

2014-01-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• suspected thrombophilia
• 18 years of age or older

You may not qualify if…

• none

Where it is running

• Sequenom Center for Molecular Medicine — Grand Rapids, Michigan, United States
• Oregon Health & Science University — Portland, Oregon, United States
• The Methodist Hospital Research Institute — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.